Guardian Pharmacy Services
GRDN
112 hedge funds and large institutions have $517M invested in Guardian Pharmacy Services in 2025 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 56 increasing their positions, 23 reducing their positions, and 16 closing their positions.
143% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 23
44% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 16
34% more capital invested
Capital invested by funds: $388M → $517M (+$130M)
7% more funds holding
Funds holding: 105 → 112 (+7)
6.5% more ownership
Funds ownership: 80.06% → 86.57% (+6.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
Valiant Capital Management
San Francisco,
California
|
+$25.4M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$20.1M |
| 3 |
BlackRock
New York
|
+$15.2M |
| 4 |
Millennium Management
New York
|
+$7.16M |
| 5 |
ACB
Aristotle Capital Boston
Boston,
Massachusetts
|
+$5.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
-$26.9M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$13.6M |
| 3 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$12.3M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$8.28M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.76M |
GRDN Hedge Fund Activity: Q3 2025 in Review
112 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Guardian Pharmacy Services (GRDN) for Q3 2025, worth a combined $517M — up 34% from $388M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new GRDN positions and 16 closed out — a net gain of 7 holders — while 56 added to existing stakes and 23 trimmed.
The largest buyer was Valiant Capital Management, opening a new position worth an estimated $25.4M. The largest seller was J. Goldman & Co, cutting an estimated $26.9M.
- 112 institutional investors held Guardian Pharmacy Services (GRDN) as of Q3 2025, up from 105 in Q2 2025.
- Funds reported $517M of Guardian Pharmacy Services stock for Q3 2025, up 34% quarter-over-quarter.
- 23 funds opened new Guardian Pharmacy Services positions in Q3 2025 and 16 closed out, a net change of +7 holders.
- The largest Guardian Pharmacy Services buyer in Q3 2025 was Valiant Capital Management, an estimated $25.4M added.
- The largest Guardian Pharmacy Services seller in Q3 2025 was J. Goldman & Co, an estimated $26.9M sold.
Based on aggregated 13F filings for Q3 2025.